Subscribe for the newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Cerevance
Sort By
Newest First
Sign in
1 / 1
1 / 1
Industry Challenges
What do you consider the biggest challenge that the pharma/biopharma industry currently faces?
Pharma's Almanac
O-06-022--RT-01
Jun 24, 2022
Biotechs
10 Promising Biotechs Aiming to Transform Medicine
David Alvaro, Ph.D.; Danielle Alvarez
Pharma's Almanac
PA564
Mar 22, 2022
Neurodegenerative Diseases
Uncovering New Drug Targets for Neurological Diseases
Brad Margus
Cerevance
PAO-02-022-CL-10
Mar 12, 2022
Clinical Trials
Cerevance Achieves Key Endpoints in Phase 1 Clinical Trial of Novel Parkinson’s Disease Drug CVN424
Cerevance
PR-M05-19-NI-011
May 03, 2019
